natgillin/translations-raw huggingface dataset:
This means that Ifirmacombi is similar to a ‘reference medicine’ already authorised in the European Union (EU) called CoAprovel.
See tähendab, et Ifirmacombi on sarnane võrdlusravimiga CoAprovel, millel juba on Euroopa Liidus müügiluba.
This means that Ifirmasta is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aprovel.
See tähendab, et Ifirmasta on sarnane võrdlusravimiga Aprovel, millel juba on Euroopa Liidus müügiluba.
This means that Imatinib Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Glivec.
See tähendab, et Imatinib Accord on sarnane võrdlusravimiga Glivec, millel juba on Euroopa Liidus müügiluba.
This means that Imatinib Actavis is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Glivec.
See tähendab, et Imatinib Actavis on sarnane võrdlusravimiga Glivec, millel juba on Euroopa Liidus müügiluba.
This means that Imatinib medac is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Glivec.
See tähendab, et Imatinib medac on sarnane võrdlusravimiga Glivec, millel juba on Euroopa Liidus müügiluba.
This means that Imatinib Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Glivec.
See tähendab, et Imatinib Teva on sarnane võrdlusravimiga Glivec, millel juba on Euroopa Liidus müügiluba.
This means that Inflacam is similar to a ‘reference medicine’ already authorised in the EU called Metacam.
See tähendab, et see sarnaneb võrdlusravimiga Metacam, millel juba on Euroopa Liidus müügiluba.
This means that Inflectra is similar to a biological medicine (the ‘reference medicine’) that is already authorised in the European Union (EU) and that Inflectra and the reference medicine contain the same active substance.
See tähendab, et Inflectra on sarnane bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet.
This means that Inhixa is highly similar to a biological medicine (also known as the ‘reference medicine’) that is already authorised in the European Union (EU).
See tähendab, et Inhixa sarnaneb bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba.
This means that Irbesartan Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aprovel.
See tähendab, et Irbesartan Teva on sarnane võrdlusravimiga Aprovel, millel juba on Euroopa Liidus müügiluba.
This means that Irbesartan/Hydrochlorothiazide Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called CoAprovel.
See tähendab, et Irbesartan/Hydrochlorothiazide Teva on sarnane võrdlusravimiga CoAprovel, millel juba on Euroopa Liidus müügiluba.
This means that it affects the activity of the immune system (the body’s natural defences).
See tähendab, et see mõjutab immuunsüsteemi (organismi loomulikku kaitsesüsteemi).
This means that it alters the activity of the immune system (the body’s natural defences).
See muudab immuunsüsteemi (organismi loodusliku kaitsemehhanismi) toimimist.
This means that it attaches to opioid receptors and acts like the body’s natural opioids to calm down waves of contractions along the digestive system.
See tähendab, et toimeaine seondub opioidiretseptoriga ja toimib samamoodi kui organismi looduslikud opioidid, aeglustades seedetrakti kontraktsioonilaineid (peristaltikat).
This means that it attaches to the muscle relaxants rocuronium and vecuronium forming a ‘complex’ that inactivates the muscle relaxants and stops them having an effect.
See tähendab, et ravim seondub müorelaksantide rokurooniumi ja vekurooniumi molekuliga, moodustades kompleksi, mis inaktiveerib müorelaksandid ja peatab nende toime.
This means that it blocks a specific type of opioid receptor called the ‘mu-opioid receptor’.
See tähendab, et toimeaine blokeerib teatud tüüpi opioidiretseptorid, mida nimetatakse μ-opioidi retseptoriteks.
This means that it blocks the proteasome, which is a system within the cells that breaks down proteins when they are no longer needed.
Toimeaine blokeerib proteasoomi ehk rakusisese süsteemi, mis lagundab valke, kui neid enam ei vajata.
This means that it has not been possible to obtain complete information about Bluevac BTV8.
See tähendab, et Bluevac BTV8 kohta ei ole olnud võimalik hankida täielikku teavet.
This means that it has yet not been possible to obtain complete information about Poulvac FluFend H5N3 RG.
See tähendab, et ravimi kohta ei ole olnud võimalik täielikku teavet saada.
This means that it helps to prevent cells in the blood called platelets sticking together (aggregating).
See tähendab, et ravim aitab ennetada teatud vererakkude – trombotsüütide (vereliistakute) – agregatsiooni (kokkukleepumist).
This means that it is converted into amfenac in the eye.
See tähendab, et ravim muundub silmas amfenakiks.
This means that it is converted to aprepitant in the body.
See tähendab, et see muundub organismis aprepitandiks.
This means that it is essentially ‘sodium-free’.
See tähendab, et ravim on praktiliselt naatriumivaba.
This means that it is essentially “sodium-free”.
See tähendab, et ta on praktiliselt “naatriumivaba”.
This means that it is injected through a short injection needle into the fatty tissue just under the skin.
See tähendab, et ravim süstitakse lühikese süstlanõela abil vahetult naha all asuvasse rasvkoesse.
This means that it is similar to a reference medicine, containing the same active substance but in a different concentration.
See tähendab, et Methylthioninium chloride Proveblue sarnaneb võrdlusravimiga, mis sisaldab sama toimeainet, kuid muus kontsentratsioonis.
This means that it is similar to a ‘reference medicine’ (in this case Lantarel FS) containing the same active substance (methotrexate).
See tähendab, et ta sarnaneb võrdlusravimiga Lantarel FS, mis sisaldab sama toimeainet (metotreksaat).
This means that it is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Rebetol.
See tähendab, et Ribavirin Teva on sarnane võrdlusravimiga Rebetol, millel juba on Euroopa Liidus müügiluba.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but available at a new strength in addition to existing strengths.
See on sarnane võrdlusravimiga, sisaldades sama toimeainet, kuid ravimit turustatakse lisaks olemasolevatele uues tugevuses.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but given in a different way.
See tähendab, et Sancuso on sarnane võrdlusravimiga, mis sisaldab sama toimeainet, aga mida manustatakse teistmoodi.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but Pheburane granules are available at a lower strength and contain different excipients (inactive ingredients) to mask the unpleasant taste of the active substance.
See tähendab, et Pheburane on sarnane võrdlusravimiga, mis sisaldab sama toimeainet, aga Pheburane graanuleid turustatakse väiksema tugevusega ja need sisaldavad teisi abiaineid, mis varjavad toimeaine ebameeldivat maitset.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but Procysbi is available in a formulation that allows for a delayed release of the active substance in the body.
See tähendab, et Procysbi on sama toimeainet sisaldava võrdlusravimiga sarnane, kuid Procysbit turustatakse ravimvormis, mis võimaldab toimeainet viivitatult organismi vabastada.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but Raxone contains idebenone at a different strength.
See tähendab, et Raxone on sarnane võrdlusravimiga, mis sisaldab sama toimeainet, kuid Raxonet turustatakse teise tugevusega.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but Zalviso is available in a different form.
See tähendab, et Zalviso on sarnane võrdlusravimiga, mis sisaldab sama toimeainet, kuid Zalvisot turustatakse teise tugevusega.
This means that it is similar to a ‘reference medicine’ containing the same active substance, but Zyclara is available in a different strength.
See tähendab, et Zyclara on sarnane võrdlusravimiga, mis sisaldab sama toimeainet, kuid Zyclarat turustatakse teise tugevusega.
This means that it is similar to a ‘reference medicine’ containing the same active substance.
See tähendab, et ta on sarnane võrdlusravimiga, mis sisaldab sama toimeainet.
This means that it is similar to a ‘reference medicine’ containing the same active substances, but BiResp Spiromax is given using a different inhaler.
See tähendab, et BiResp Spiromax on sarnane võrdlusravimiga, mis sisaldab samu toimeaineid, kuid ravimit BiResp Spiromax manustatakse teiste inhalaatoriga.
This means that it is similar to a ‘reference medicine’ containing the same active substances, but Budesonide/Formoterol Teva is given using a different inhaler.
See tähendab, et Budesonide/Formoterol Teva on sarnane võrdlusravimiga, mis sisaldab samu toimeaineid, kuid seda manustatakse teise inhalaatoriga.
This means that it is similar to a ‘reference medicine’ containing the same active substances, but DuoResp Spiromax is given using a different inhaler.
See tähendab, et DuoResp Spiromax on sarnane võrdlusravimiga, mis sisaldab samu toimeaineid, kuid ravimit DuoResp Spiromax manustatakse teise inhalaatoriga.
This means that it is similar to a ‘reference medicine’ containing the same active substances, but Vylaer Spiromax is given using a different inhaler.
See tähendab, et Vylaer Spiromax on sarnane võrdlusravimiga, mis sisaldab samu toimeaineid, kuid ravimit Vylaer Spiromax manustatakse teise inhalaatoriga.
This means that it is similar to a ‘reference medicine’, but it contains aripiprazole at a new strength in addition to existing strengths: while the reference medicine, Abilify, is available as 5, 10, 15 and 30 mg, Aripiprazole Sandoz is also available as 20 mg tablets.
See tähendab, et ravim on sarnane võrdlusravimiga, kuid sisaldab aripiprasooli lisaks olemasolevatele tugevustele ka uues tugevuses: võrdlusravimit Abilify turustatakse tugevustes 5 mg, 10 mg, 15 mg ja 30 mg, ravimit Aripiprazole Sandoz turustatakse ka 20 mg tablettidena.
This means that it is similar to a ‘reference medicine’, but it contains capecitabine at a new strength in addition to existing strengths.
See on sarnane võrdlusravimiga, kuid sisaldab kapetsitabiini lisaks senistele ravimitugevustele uues tugevuses.
This means that it is similar to one or more ‘reference medicines’ already authorised in the European Union (EU).
See tähendab, et Zoledronic Acid Hospira on sarnane ühe või mitme võrdlusravimiga, millel juba on Euroopa Liidus müügiluba.
This means that it is similar to ‘reference medicines’ containing the same active substance, but given in a different way.
See tähendab, et see on sarnane võrdlusravimiga, mis sisaldab sama toimeainet, kuid seda manustatakse erineval viisil.
This means that it kills
See tähendab, et ravim hävitab parasiite,
This means that it kills parasites like nematodes that live inside the body of animals.
See tähendab, et ravim hävitab loomade organismis elavaid parasiite, nagu ümarussid.
This means that it kills parasites that live on the skin or in the fur of animals, such as fleas and ticks.
See tähendab, et ravim hävitab parasiite, kes elavad loomade nahal või karvades, nagu kirbud või puugid.
This means that it reduces the activity of the immune system (the body’s natural defences).
See tähendab, et see vähendab immuunsüsteemi (organismi loomuliku kaitsemehhanismi) aktiivsust.
This means that it stimulates the receptor for oestrogen in some tissues in the body such as the vagina.
See tähendab, et ospemifeen stimuleerib organismi teatud kudedes, nt tupes, östrogeeni retseptorit.
This means that it stops a chemical in the body called 5-hydroxytryptamine (5HT, also known as serotonin) from attaching to 5HT3 receptors in the gut.
See takistab organismi teatud keemilise aine 5- hüdroksütrüptamiini (5HT ehk serotoniini) seondumist soolestiku 5HT3-retseptoritega.
This means that it stops a chemical in the body called 5-hydroxytryptamine (5HT, also known as serotonin) from attaching to 5HT3 receptors in the gut.
See takistab organismi teatud keemilise aine 5-hüdroksütrüptamiini (5HT ehk serotoniini) seondumist soolestiku 5HT3- retseptoritega.
This means that it uses the immune system, the body’s natural defences, to bring about its effect.
See tähendab, et see toimib immuunsüsteemi (ogranismi loomulike kaitsemehhanismide) abil.
This means that it widens the airways by blocking some receptors in muscle cells in the lungs called
See tähendab, et ravim laiendab hingamisteid, blokeerides kopsu silelihasrakkude teatud retseptoreid
This means that it widens the airways by blocking some receptors in muscle cells in the lungs called
See tähendab, et ravim laiendab hingamisteid, blokeerides kopsu silelihasrakkude teatud retseptoreid (muskariiniretseptorid), mis juhivad lihaste kokkutõmbumist.
This means that it will kill parasites that live on or in the skin or in the fur of animals, such as fleas, ticks, lice and Demodex mites (mites that cause demodicosis or ‘mange’).
See tähendab, et ravim hävitab parasiidid, kes elavad looma karvades, naha peal või selle sees, nagu kirbud, puugid, täid ja täid ja vagellestad (Demodex; põhjustavad demodikoosi).
This means that it will start to lower your blood sugar about half an hour after you take it.
See tähendab, et Velosulin’i veresuhkrut langetav toime algab pool tundi pärast manustamist.
This means that it works in a similar way to prostacyclin, a naturally occurring substance that regulates blood pressure by attaching to receptors in the muscles of blood vessel walls, causing the vessels to relax and widen.
See tähendab, et seleksipaag toimib sarnaselt prostatsükliinile – organismis looduslikult esinevale ainele, mis reguleerib vererõhku sellega, et seondub veresoonte seinte lihastes olevate retseptoritega, lõõgastades ja laiendades nii veresooni.
This means that Lamivudine Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Zeffix.
See tähendab, et Lamivudine Teva on sarnane võrdlusravimiga Zeffix, millel juba on Euroopa Liidus müügiluba.
This means that Lamivudine Teva Pharma B.V. is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Epivir.
See tähendab, et Lamivudine Teva Pharma B.V. on sarnane võrdlusravimiga Epivir, millel juba on Euroopa Liidus müügiluba.
This means that Lamivudine/Zidovudine Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Combivir.
See tähendab, et Lamivudine / Zidovudine Teva on sarnane võrdlusravimiga Combivir, millel juba on Euroopa Liidus müügiluba.
This means that Leflunomide medac is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Arava.
See tähendab, et Leflunomide medac on sarnane võrdlusravimiga Arava, millel juba on Euroopa Liidus müügiluba.
This means that Leflunomide ratiopharm is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Arava.
See tähendab, et Leflunomide ratiopharm on sarnane võrdlusravimiga Arava, millel juba on Euroopa Liidus müügiluba.
This means that Leflunomide Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Arava.
See tähendab, et Leflunomide Teva on sarnane võrdlusravimiga Arava, millel juba on Euroopa Liidus müügiluba.
This means that Levetiracetam Actavis Group is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Keppra.
See tähendab, et Levetiracetam Actavis Group on sarnane võrdlusravimiga Keppra, millel juba on Euroopa Liidus müügiluba.
This means that Levetiracetam Sun is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Keppra.
See tähendab, et Levetiracetam Sun on sarnane võrdlusravimiga Keppra, millel juba on Euroopa Liidus müügiluba.
This means that Levetiracetam Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Keppra.
See tähendab, et Levetiracetam Teva on sarnane võrdlusravimiga Keppra, millel juba on Euroopa Liidus müügiluba.
This means that Marixino is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Ebixa.
See tähendab, et Marixino on sarnane võrdlusravimiga Ebixa, millel juba on Euroopa Liidus müügiluba.
This means that Matever is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Keppra.
See tähendab, et Matever on sarnane võrdlusravimiga Keppra, millel juba on Euroopa Liidus müügiluba.
This means that Melovem is similar to a ‘reference veterinary medicine’ containing the same active substance.
See tähendab, et ta sarnaneb võrdlus-veterinaarravimiga, mis sisaldab sama toimeainet.
This means that Meloxidolor is similar to a ‘reference veterinary medicine’ containing the same active substance, but it is also available at a higher strength.
See tähendab, et Meloxidolor on sarnane võrdlusravimiga ja sisaldab sama toimeainet, kuid seda turustatakse ka suurema tugevusega.
This means that Memantine Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Axura.
See tähendab, et Memantine Accord on sarnane võrdlusravimiga Axura, millel juba on Euroopa Liidus müügiluba.
This means that Memantine LEK is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Ebixa.
See tähendab, et Memantine LEK on sarnane võrdlusravimiga Ebixa, millel juba on Euroopa Liidus müügiluba.
This means that Memantine Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Ebixa.
See tähendab, et Memantine Mylan on sarnane võrdlusravimiga Ebixa, millel juba on Euroopa Liidus müügiluba.
This means that Memantine ratiopharm is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Ebixa.
See tähendab, et Memantine ratiopharm on sarnane võrdlusravimiga Ebixa, millel juba on Euroopa Liidus müügiluba.
This means that Myclausen is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Cellcept.
See tähendab, et Myclausen on sarnane võrdlusravimiga Cellcept, millel juba on Euroopa Liidus müügiluba.
This means that Mycophenolate mofetil Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called CellCept.
See tähendab, et Mycophenolate mofetil Teva on sarnane võrdlusravimiga CellCept, millel juba on Euroopa Liidus müügiluba.
This means that Myfenax is similar to a ‘reference medicine’ already authorised in the European Union (EU) called CellCept.
See tähendab, et Myfenax on sarnane võrdlusravimiga CellCept, millel juba on Euroopa Liidus müügiluba.
This means that Nemdatine is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Ebixa.
See tähendab, et Nemdatine on sarnane võrdlusravimiga Ebixa, millel juba on Euroopa Liidus müügiluba.
This means that Nevirapine Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Viramune.
See tähendab, et Nevirapine Teva on sarnane võrdlusravimiga Viramune, millel juba on Euroopa Liidus müügiluba.
This means that Nimvastid is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Exelon.
See tähendab, et Nimvastid on sarnane võrdlusravimiga Exerol, millel juba on Euroopa Liidus müügiluba.
This means that Nivestim is similar to a biological medicine (the ‘reference medicine’) that is already authorised in the European Union (EU) and contains the same active substance as the reference medicine.
See tähendab, et Nivestim on sarnane bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet.
This means that Novaquin is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Metacam.
See tähendab, et Novaquin on sarnane võrdlusravimiga Metacam, millel juba on Euroopa Liidus müügiluba.
This means that Olanzapine Apotex is similar to ‘reference medicines’ already authorised in the European Union (EU) called Zyprexa and Zyprexa Velotab.
See tähendab, et Olanzapine Apotex on sarnane võrdlusravimitega Zyprexa ja Zyprexa Velotab, millel juba on Euroopa Liidus müügiluba.
This means that Olanzapine Cipla is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Zyprexa.
See tähendab, et Olanzapine Cipla on sarnane võrdlusravimiga Zyprexa, millel juba on Euroopa Liidus müügiluba.
This means that Olanzapine Glenmark Europe is similar to ‘reference medicines’ already authorised in the European Union (EU) called Zyprexa and Zyprexa Velotabs.
See tähendab, et Olanzapine Glenmark Europe on sarnane võrdlusravimitega Zyprexa ja Zyprexa Velotab, millel juba on Euroopa Liidus müügiluba.
This means that Olanzapine Glenmark is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Zyprexa.
See tähendab, et Olanzapine Glenmark on sarnane võrdlusravimiga Zyprexa, millel juba on Euroopa Liidus müügiluba.
This means that Olanzapine Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Zyprexa.
See tähendab, et Olanzapine Mylan on sarnane võrdlusravimiga Zyprexa, millel juba on Euroopa Liidus müügiluba.
This means that Olanzapine Teva is similar to ‘reference medicines’ already authorised in the European Union (EU) called Zyprexa and Zyprexa Velotab.
See tähendab, et Olanzapine Teva on sarnane võrdlusravimitega Zyprexa ja Zyprexa Velotab, millel juba on Euroopa Liidus müügiluba.
This means that Olazax Disperzi is similar to ‘reference medicines’ already authorised in the European Union (EU) called Zyprexa and Zyprexa Velotab.
See tähendab, et Olazax Disperzi on sarnane võrdlusravimitega Zyprexa ja Zyprexa Velotab, millel juba on Euroopa Liidus müügiluba.
This means that Olazax is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Zyprexa.
See tähendab, et Olazax on sarnane võrdlusravimiga Zyprexa, millel juba on Euroopa Liidus müügiluba.
This means that Omnitrope is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘reference medicine’).
See tähendab, et Omnitrope sarnaneb Euroopa Liidus juba müügiloa saanud bioloogilisele ravimile ning sisaldab sama toimeainet (tuntud ka kui võrdlusravim).
This means that Oprymea is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Sifrol (also known as Mirapexin).
See tähendab, et Oprymea on sarnane võrdlusravimiga Sifrol (teise nimega Mirapexin), millel juba on Euroopa Liidus müügiluba.
This means that Ovaleap is similar to a biological medicine (the ‘reference medicine’) that is already authorised in the European Union (EU) and that Ovaleap and the reference medicine contain the same active substance.
See tähenda, et Ovaleap on sarnane bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet.
This means that Paglitaz is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Actos.
See tähendab, et Paglitaz on sarnane võrdlusravimiga Actos, millel juba on Euroopa Liidus müügiluba.
This means that Palonosetron Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aloxi.
See tähendab, et Palonosetron Accord on sarnane võrdlusravimiga Aloxi, millel juba on Euroopa Liidus müügiluba.
This means that Palonosetron Hospira is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aloxi.
See tähendab, et Palonosetron Hospira on sarnane võrdlusravimiga Aloxi, millel juba on Euroopa Liidus müügiluba.
This means that Pemetrexed Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Alimta.
See tähendab, et Pemetrexed Accord on sarnane võrdlusravimiga Alimta, millel juba on Euroopa Liidus müügiluba.